Login / Signup

EUCAST rapid antimicrobial susceptibility testing (RAST) compared to conventional susceptibility testing: implementation and potential added value in a tertiary hospital in Belgium.

Gregory StrubbeAnne-Sophie MessiaenStien VandendriesscheBruno VerhasseltJerina Boelens
Published in: Acta clinica Belgica (2023)
EUCAST RAST is an inexpensive and reliable method of susceptibility testing, although care must be taken with reporting piperacillin/tazobactam. In support of RAST implementation, we show that AST remains of great importance in providing effective therapy, even in a setting of low MDR prevalence and elaborate antibiotic guidelines.
Keyphrases
  • healthcare
  • quality improvement
  • primary care
  • multidrug resistant
  • risk factors
  • palliative care
  • stem cells
  • gram negative
  • risk assessment
  • adverse drug
  • health insurance